porno izle
porno
erotik film
asyabahis
women desperate to piss ava addams mom porn sa akin ang gabi

Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.

To 'Post Your News' use the button at the top right.



Neuronostics is developing BioEP in partnership with the University of Birmingham

University spinout company Neuronostics has received funding to develop its BioEP platform, an AI-based system for faster, more accurate diagnosis of epilepsy and to monitor response to treatment with anti-epileptic drugs (AEDs). 

Read the rest of entry »

Enesi Pharma to Develop Thermostable, Solid Dose DNA Vaccine Targeting Zika Virus under New Partnership with The University of Adelaide

OXFORD, UK – 03 September 2020 – Enesi Pharma (“Enesi”), an innovative biotechnology company developing next-generation vaccination products targeting serious diseases, is delighted to announce its partnership with the University of Adelaide to develop a new thermostable, solid dose DNA vaccine for Zika virus to prevent infection of pregnant women and the resultant congenital effects in the unborn child.

Read the rest of entry »

Yourgene Health: Today announces the launch of IONA® Nx NIPT workflow

Manchester, UK : Yourgene (AIM: YGEN), the international molecular diagnostics group, announced today  the launch of IONA® Nx NIPT workflow, the Company’s new innovative non-invasive prenatal test (‘NIPT’). The IONA Nx seeks to offer clinical labs a high performing, flexible, scalable and innovative NIPT service inhouse and is developed to run on the Illumina Nextseq 550 Dx platform for next generation sequencing.

Read the rest of entry »

Horton International UK: Announce the appointment of Mark Johnson as Senior Partner of its Oxford-based Global Healthcare arm.

Executive search consultancy, Horton International UK, has announced the appointment of Mark Johnson as Senior Partner of its Oxford-based Global Healthcare arm.

Read the rest of entry »

AMSBIO: Optimized Freezing Solutions for Clinical Application of Cell Therapy Products

AMSBIO announce new additions and certifications for their market-leading range of clinical grade, chemically defined cryopreservation excipient solutions - STEM-CELLBANKER® and HSC-BANKER®.

STEM-CELLBANKER® DMSO Free GMP grade is a new chemically defined freezing solution that does not contain DMSO as an anti-freezing agent. It was developed for customers who prefer not to use DMSO-containing cryopreservation solution due to the intended application of the samples. STEM-CELLBANKER® DMSO Free GMP grade is manufactured in compliance with JPN, EU, US, and PIC/S GMP guidelines.

Read the rest of entry »

Taylor Wessing Webinar: 'Optimising exits for European technology companies'

In collaboration with Silverpeak, this session will provide practical guidelines and best practice for those seeking to sell or make a partial realisation in the current environment. You will hear real life stories from an entrepreneur's recent exit experience together with a viewpoint from the private equity industry. 

TaylorWessing, new OBN sponsors are offering this webinar on Thursday 17 September 2020, 0830 - 1000.  Click here to REGISTER.

Antiviral nanomaterials join the fight against SARS-Cov-2

Vaccitech receives government grant for COVID-19 vaccine research

Oxford, UK: Vaccitech Limited, a clinical-stage biopharmaceutical company developing immunotherapies to treat and prevent infectious diseases and cancer, announces today that it has received a non-dilutive Government grant to support research with its next-generation technology platform to protect against COVID-19. The grant is part of the UKRI-NIHR COVID-19 rapid response rolling call for proposals with potential to deliver public health impacts within 12 months. Preclinical data indicate Vaccitech’s new platform induces leading antibody and cell-mediated immune responses, two arms of the immune system known to protect against disease, when compared with the adenoviral platforms currently in vaccine trials for COVID-19. The preclinical data informed the decision of UK Research and Innovation (UKRI) and the National Institute for Health Research (NIHR), and other funders including the World Health Organization (WHO), to support Vaccitech’s research efforts. Vaccitech was awarded £1 ...

Read the rest of entry »

Oxford Nanopore: Nanopore sequencing 101 - online seminar series is back!

The first in the series will be hosted by James Brayer — Associate Director, Market Development, Oxford Nanopore Technologies — on 8th September at 5pm (BST). Join James for an introduction to nanopore sequencing and be sure to bring your questions along for a Q&A which will follow the presentation.

Registration link

AMSBIO: New Cytometry Service Provides Automated Analysis of Fluorescent Biomarkers

AMSBIO announce a new service designed to provide high-content cytometry data on cells and tissues enabling the automated analysis of fluorescent biomarkers on living cells or long-term stored biobanked cells and tissues.  Leveraging the innovative ChipCytometry platform, AMSBIO is able to offer a complete workflow solution (products and services) for high-content cytometry on cells and tissues, from sample preparation and biobanking to biomarker analysis and data mining. The ChipCytometry platform operates by immobilizing cells in microfluidic chips, which are later stained with antibodies for multiplex biomarker detection. Using the ChipCytometry platform - AMSBIO can offer quantitative analysis of a virtually unlimited number of protein biomarkers in a single sample. AMSBIO is also to offer custom assays facilitating analysis of almost any antibody / biomarker target. Not only can this technology deliver quantitative biomarker analysis but it ca ...

Read the rest of entry »

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.